UNICA IRIS Institutional Research Information System

CORONA, ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 273.652
NA - Nord America 12.816
AS - Asia 5.393
SA - Sud America 842
Continente sconosciuto - Info sul continente non disponibili 706
AF - Africa 202
OC - Oceania 14
Totale 293.625
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 270.654
US - Stati Uniti d'America 12.532
SG - Singapore 2.058
CN - Cina 1.725
SE - Svezia 703
BR - Brasile 626
UA - Ucraina 507
VN - Vietnam 487
DE - Germania 377
FI - Finlandia 309
FR - Francia 260
GB - Regno Unito 252
HK - Hong Kong 193
BD - Bangladesh 173
CA - Canada 149
IN - India 147
BY - Bielorussia 120
KR - Corea 93
NL - Olanda 92
AR - Argentina 91
RU - Federazione Russa 74
JP - Giappone 64
AT - Austria 62
MA - Marocco 61
IQ - Iraq 56
MX - Messico 54
PK - Pakistan 54
TR - Turchia 44
ZA - Sudafrica 42
ES - Italia 41
PL - Polonia 41
IL - Israele 40
ID - Indonesia 32
IR - Iran 32
EC - Ecuador 31
BE - Belgio 30
SA - Arabia Saudita 30
CO - Colombia 27
IE - Irlanda 22
VE - Venezuela 21
UZ - Uzbekistan 20
KE - Kenya 16
PH - Filippine 16
SC - Seychelles 16
TN - Tunisia 16
AE - Emirati Arabi Uniti 15
CL - Cile 15
EG - Egitto 15
TW - Taiwan 15
CZ - Repubblica Ceca 13
JM - Giamaica 13
JO - Giordania 13
NP - Nepal 13
AZ - Azerbaigian 12
LT - Lituania 12
AU - Australia 11
MY - Malesia 11
NI - Nicaragua 11
CR - Costa Rica 10
DK - Danimarca 10
HN - Honduras 10
BO - Bolivia 9
ET - Etiopia 9
DZ - Algeria 8
GE - Georgia 8
GT - Guatemala 8
LV - Lettonia 8
PT - Portogallo 8
UY - Uruguay 8
AL - Albania 7
CH - Svizzera 7
EU - Europa 7
TT - Trinidad e Tobago 7
AM - Armenia 6
CW - ???statistics.table.value.countryCode.CW??? 6
GR - Grecia 6
HU - Ungheria 6
KG - Kirghizistan 6
NO - Norvegia 6
PY - Paraguay 6
PE - Perù 5
PR - Porto Rico 5
RO - Romania 5
GP - Guadalupe 4
HR - Croazia 4
PA - Panama 4
DO - Repubblica Dominicana 3
EE - Estonia 3
KZ - Kazakistan 3
LB - Libano 3
MU - Mauritius 3
NZ - Nuova Zelanda 3
OM - Oman 3
QA - Qatar 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
TH - Thailandia 3
A1 - Anonimo 2
BA - Bosnia-Erzegovina 2
Totale 292.892
Salva come PNG Salva come JPEG
Città #
Cagliari 263.199
Uta 6.195
Ashburn 1.592
Singapore 1.117
San Jose 868
Fairfield 842
Woodbridge 703
Dallas 573
Chandler 560
Boardman 482
Nyköping 431
Houston 420
Seattle 366
Beijing 357
Wilmington 347
Council Bluffs 329
Los Angeles 314
Ann Arbor 313
Cambridge 281
New York 272
Jacksonville 226
Santa Clara 208
Helsinki 207
Dearborn 191
Hong Kong 168
Shanghai 155
The Dalles 154
Ho Chi Minh City 142
Lauterbourg 134
Hefei 117
Boston 114
Nanjing 109
Rome 105
Dong Ket 98
Chicago 92
Hanoi 84
Seoul 81
Buffalo 76
Milan 75
Columbus 71
San Diego 65
Munich 61
Redwood City 61
São Paulo 56
Phoenix 52
Herndon 47
Tokyo 47
Casablanca 44
Vienna 42
Atlanta 41
Orem 41
Guangzhou 40
London 39
Toronto 39
Amsterdam 38
Hangzhou 38
Redondo Beach 37
Changsha 36
Tianjin 35
Frankfurt am Main 34
Mountain View 32
Sassari 32
Washington 31
Brooklyn 30
Denver 30
Naples 30
Nanchang 29
Rio de Janeiro 29
Verona 29
Shenyang 28
Warsaw 28
Salt Lake City 27
Redmond 26
Chennai 25
Montreal 24
Nuremberg 24
San Francisco 24
Jiaxing 23
Hebei 22
Lappeenranta 22
Johannesburg 21
Brussels 20
Mumbai 20
Norwalk 20
Baghdad 19
Dublin 19
Mexico City 19
Tashkent 19
Manchester 17
Ottawa 17
Gujranwala 16
North Bergen 16
Curitiba 15
Dhaka 15
Guayaquil 15
Lahore 15
Tampa 15
Wuhan 15
Zhengzhou 15
Charlotte 14
Totale 283.948
Salva come PNG Salva come JPEG
Nome #
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro- 1H -indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 14.757
Exploring the thiazole scaffold for the identification of new agents for the treatment of fluconazole resistant Candida 5.080
Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase 4.710
Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase 4.562
Quercetin blocks Ebola Virus infection by counteracting the VP24 Interferon inhibitory function 4.510
Biological activities of aerial parts extracts of Euphorbia characias 4.461
Ribonuclease H/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: mechanistic studies on the allosteric mode of action of isatin-based compound RMNC6 4.360
Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase 4.209
Identification of Myricetin as Ebolavirus VP35-dsRNA interaction inhibitor through a novel fluorescence-based assay 3.778
Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 Reverse transcriptase-associated RNase H and RDDP functions 3.535
Uvaria angolensis as a promising source of inhibitors of HIV-1 RT-associated RNA-dependent DNA polymerase and RNase H functions 3.480
Dual HIV-1 reverse transcriptase and integrase inhibitors from Limonium morisianum Arrigoni, an endemic species of Sardinia (Italy) 3.469
Sennoside A, derived from the traditional chinese medicine plant Rheum L., is a new dual HIV-1 inhibitor effective on HIV-1 replication 3.461
Onopordum illyricum L.: new anti HIV-1 agents from a Mediterranean edible plant 3.451
Through scaffold modification to 3,5-diaryl-4,5-dihydroisoxazoles: new potent and selective inhibitors of monoamine oxidase B 3.395
Design and synthesis of new isatin derivatives as HIV-1 reverse transcriptase associated ribonuclease H inhibitors 3.385
Molecular Aspects of the RT/drug Interactions. Perspective of Dual Inhibitors 3.339
Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors 3.339
Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action 3.327
Insights into the homo-oligomerization properties of N-terminal coiled-coil domain of Ebola virus VP35 protein 3.298
N-Acylbenzenesulfonamide dihydro-1,3,4-oxadiazole hybrids: seeking selectivity toward carbonic anhydrase isoforms 3.235
Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques 3.142
Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors 3.124
Inhibition of HIV-1 reverse transcriptase dimerization by small molecules 3.103
Relevance of Ebola virus VP35 homo-dimerization on the type I interferon cascade inhibition 3.088
Prenylated phloroglucinols from Hypericum scruglii, an endemic species of Sardinia (Italy), as new dual HIV-1 inhibitors effective on HIV-1 replication 3.069
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Dual Inhibitors of HIV-1 RT. 3.066
Insights into Ebola Virus VP35 and VP24 Interferon inhibitory functions and their initial exploitation as drug targets 3.031
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) enlighten the mechanism of action of a new Ribonuclease H/DNA polymerase RT dual inhibitor 3.019
Onopordum illyricum L., a Mediterranean plant, as a source of anti HIV-1 compounds 3.017
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Single Site Dual Inhibitors of HIV-1 RT 2.973
Preliminary study of endemic plants of Sardinia as a source of new antiviral agents 2.963
From the traditional Chinese medicine plant Schisandra chinensis new scaffolds effective on HIV-1 reverse transcriptase resistant to non-nucleoside inhibitors 2.952
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) shed light on the mechanism of action of a new Ribonuclease H/ DNA polymerase RT dual inhibitor 2.945
Structure-guided approach identifies a novel class of HIV-1 Ribonuclease H inhibitors: Binding mode insights through magnesium complexation and site-directed mutagenesis studies 2.907
Hypericum hircinum L. components as new single-molecule inhibitors of both HIV-1 reverse transcriptase-associated DNA polymerase and ribonuclease H activities 2.896
Chelation motifs affecting metal-dependent viral enzymes: N′-acylhydrazone ligands as dual target inhibitors of HIV-1 Integrase and Reverse Transcriptase Ribonuclease H domain 2.893
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 2.883
Natural Product Kuwanon-L Inhibits HIV-1 Replication through Multiple Target Binding 2.839
Insights into Ebola VP35 oligomerization from molecular simulations 2.836
Development and validation of a novel dual luciferase reporter gene assay to quantify Ebola virus VP24 inhibition of IFN signaling 2.805
Mutagenic study on HIV-1 reverse transcriptase to explore the mechanism of action of HIV-1 reverse transcriptase dual inhibitors 2.800
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity 2.749
null 2.746
New insights into the interaction between pyrrolyl diketoacids and HIV-1 integrase active site and comparison with RNase H 2.727
Synthesis and biological activity evaluation of new dual-inhibitors of both associated functions of HIV-1 RT 2.710
Active site and allosteric inhibitors of the ribonuclease H activity of HIV reverse transcriptase 2.658
3-[2-(4-aryl-1,3-thiazol-2-yl)hydrazin-1-ylidene]-1H-indol-2-ones as new potential dual inhibitors of polimerase and ribonuclease HIV-1 RT associated function 2.642
Use of a Dual Luciferase Cell-Based Drug Screening Assay to Study VP24 Inhibition of JAK/STAT Pathway and its Reversion by Compounds 2.625
Chalcones as novel dual inhibitors of HIV-1 reverse transcriptase 2.489
Structure-Activity Relationship of Pyrrolyl Diketo Acid Derivatives as Dual Inhibitors of HIV-1 Integrase and Reverse Transcriptase Ribonuclease H Domain 2.451
Meeting report: Fourth Summer School on Innovative Approaches for Identification of Antiviral Agents (IAAASS) 2.449
An efficient route to novel uracil-based drug-like molecules 2.387
Inhibitory effect of 2,3,5,6-tetrafluoro-4-[4-(Aryl)-1H-1,2,3-triazol-1-yl]benzenesulfonamide derivatives on HIV reverse transcriptase associated rnase H activities 2.385
A Luciferase Reporter Gene Assay to Measure Ebola Virus Viral Protein 35–Associated Inhibition of Double-Stranded RNA–Stimulated, Retinoic Acid–Inducible Gene 1–Mediated Induction of Interferon β 2.337
null 2.329
Exploring new scaffolds for the inibition of the Ribonuclease H function of RT HIV-1 2.295
2-(Arylamino)-6-(trifluoromethyl)nicotinic Acid Derivatives: New HIV-1 RT Dual Inhibitors Active on Viral Replication 2.285
1,2,4-Triazolo[1,5-a]pyrimidines as a Novel Class of Inhibitors of the HIV-1 Reverse Transcriptase-Associated Ribonuclease H Activity 2.239
Design and synthesis of new Isatin derivatives as HIV-1 Reverse Transcriptase associated Ribonuclease H inhibitors twenty-fourth 2.189
Isatin derivatives as new scaffolds for HIV-1 reverse transcriptase associated RNase H and RDDP dual inhibitors 2.172
Discovery of dihydroxyindole-2-carboxylic acid derivatives as dual allosteric HIV-1 Integrase and Reverse Transcriptase associated Ribonuclease H inhibitors 2.153
Targeting HIV-1 RNase H: N'-(2-Hydroxy-benzylidene)-3,4,5-Trihydroxybenzoylhydrazone as Selective Inhibitor Active against NNRTIs-Resistant Variants 2.132
Alizarine derivatives as new dual inhibitors of the HIV-1 reverse transcriptase-associated DNA polymerase and RNase H activities effective also on the RNase H activity of non-nucleoside resistant reverse transcriptases 2.131
Design, synthesis and biolgical activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 2.113
Kuwanon-L as a new allosteric HIV-1 integrase inhibitor: molecular modeling and biological evaluation 2.087
Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus 2.074
Design, synthesis and biological activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 2.019
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action 1.923
Design of new inhibitors of the HIV-1 Reverse Transcriptase associated Ribonuclease H function: a synthetic approach 1.905
Pyrrolyl Pyrazoles as Non-Diketo Acid Inhibitors of the HIV-1 Ribonuclease H Function of Reverse Transcriptase 1.900
Antiretroviral activity of metal-chelating HIV-1 integrase inhibitors 1.899
Scaffold hopping and optimisation of 3’,4’-dihydroxyphenyl- containing thienopyrimidinones: synthesis of quinazolinone derivatives as novel allosteric inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H 1.850
The traditional Chinese medicine plant Schisandra Chinensis as source of new HIV-1 reverse transcriptase inhibitor scaffolds effective also on non-nucleoside resistant reverse transcriptases 1.841
SITE DIRECT MUTAGENESIS AND KINETIC STUDIES TO EXPLORE THE MECHANISM OF ACTION OF ISATIN DERIVATIVES AS HIV-1 REVERSE TRANSCRIPTASE DUAL INHIBITORS 1.825
null 1.820
Exploring new scaffolds for the inhibition of the Ribonuclease H function of RT HIV-1 1.746
New anthraquinone derivatives as inhibitors of the HIV-1 reverse transcriptase-associated ribonuclease H function 1.737
A new vinyl selenone-based domino approach to spirocyclopropyl oxindoles endowed with anti-HIV RT activity 1.701
Flavonoids and Acid-Hydrolysis derivatives of Neo-Clerodane diterpenes from Teucrium flavum subsp. glaucum as inhibitors of the HIV-1 reverse transcriptase–associated RNase H function 1.666
Synthesis and biological evaluation of new dual inhibitors of HIV-1 associated functions 1.636
Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen 1.603
From classic to innovative approaches in HIV-1 infection treatment 1.597
Hypericum hircinum L. components as new single molecule inhibitors of both HIV-1 reverse transcriptase-associated DNA polymerase and ribonuclease H activities. 1.578
Identification of highly conserved residues involved in inhibition of HIV-1 RNase H function by Diketo acid derivatives 1.562
2-methoxynaphthalen thiazole derivate : a new HIV-1 RT Ribonuclease H/DNA polymerase dual inhibitor active on viral replication 1.549
Zika virus NS2A inhibits interferon signaling by degradation of STAT1 and STAT2 1.479
Can the ever-promising target HIV reverse transcriptase-associated RNase H become a success story for drug development? 1.456
Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production 1.455
Antiviral Agents Against Ebola Virus Infection: Repositioning Old Drugs and Finding Novel Small Molecules 1.447
Peptides Mimicking the β7/β8 loop of HIV-1 Reverse Transcriptase p51 as “Hotspot-Targeted” Dimerization Inhibitors 1.440
5-arylaminouracil derivatives as potential dual-action agents 1.369
Natural Compounds Inhibit SARS-CoV-2 nsp13 Unwinding and ATPase Enzyme Activities 1.331
Natural and Nature-Derived Products Targeting Human Coronaviruses 1.312
INMI1 Zika Virus NS4B Antagonizes the Interferon Signaling by Suppressing STAT1 Phosphorylation 1.310
Cytopathic SARS-CoV-2 screening on VERO-E6 cells in a large-scale repurposing effort 1.249
Exploring new scaffolds for the dual inhibition of HIV-1 RT polymerase and ribonuclease associated functions 1.228
A combined cell based and site directed mutagenesis approach defines highly conserved residues involved in the selective inhibition of the HIV-1 ribonuclease H function by diketoacid derivatives 1.179
In Vitro Anti-HIV-1 Reverse Transcriptase and Integrase Properties of Punica granatum L. Leaves, Bark, and Peel Extracts and Their Main Compounds 1.152
The Methanolic Extract of Perilla frutescens Robustly Restricts Ebola Virus Glycoprotein-Mediated Entry 1.078
Totale 264.888
Salva come PNG Salva come JPEG
Categoria #
all - tutte 361.624
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 361.624
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202211.886 0 0 0 903 1.139 1.247 897 907 1.513 1.470 1.799 2.011
2022/202326.453 2.280 3.722 3.079 2.423 1.570 2.878 1.282 1.827 1.399 1.519 2.128 2.346
2023/202424.258 1.620 862 1.324 1.822 2.331 4.147 3.191 2.097 1.158 1.331 2.071 2.304
2024/202550.727 13.089 15.338 7.484 4.880 2.332 2.847 2.652 236 492 377 448 552
2025/202612.949 877 412 1.483 1.103 1.099 795 2.189 1.149 829 1.512 913 588
2026/20273.699 379 657 1.036 1.627 0 0 0 0 0 0 0 0
Totale 293.625